Cellaviva Sverige May 21, 2021

Recruitment start for the ProTrans study for treatment of COVID-19

ProTrans is given with the aim of reducing hyper-inflammation within the lungs. The goal of the treatment is to shorten hospital stay and time for rehabilitation and save lives.

Cellaviva Sverige February 2, 2021
Canadian Trial for ProTrans in COVID-19

Canadian Trial for ProTrans in COVID-19

TUE, FEB 02, 2021 15:50 CET NextCell Pharma AB (“NextCell”) today announces that Health Canada and the McGill University Health Centre Research Ethics Board have authorized the clinical trial entitled...